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Histone deacetylase HDA1, the prototype for the class II mamma-
lian deacetylases, is likely the catalytic subunit of the HDA1-
containing complex that is involved in TUP1-specific repression and
global deacetylation in yeast. Although the class I RPD3-like enzy-
matic complexes have been well characterized, little is known
about the identity and interactions of the factors that associate to
form the HDA1 complex. In this paper, we identify related HDA2
and HDA3 proteins that are found in the HDA1 complex and show
that HDA1 interacts with itself and with the HDA2-HDA3 subcom-
plex to form a likely tetramer. These interactions are necessary for
catalytic activity because mutations in any of the three compo-
nents disrupt activity both in vitro and in vivo. In this respect the
HDA1 complex differs from yeast RPD3, which has components
such as SIN3 that are not essential for activity in vitro, and yeast
HOS3, which has intrinsic in vitro activity as a homodimer in the
absence of other subunits.
H istone deacetylases can be recruited to promoter elementsto deacetylate adjacent nucleosomes and repress transcrip-
tion in a background of global acetylation and deacetylation
(1–3). The deacetylases have been grouped into two classes as
determined by sequence similarity (4). Class I histone deacety-
lases are similar to RPD3 and include yeast HOS1 and HOS2 (5)
and mammalian HDAC1, HDAC2, and HDAC3 (1). These
proteins are considered to be putative catalytic subunits because
HDAC1 interacts with trapoxin, a competitive inhibitor of the
deacetylase (6). In addition, all of these proteins are homologous
to HOS3, which has intrinsic catalytic activity as a homodimer
when expressed in Escherichia coli in the absence of other
deacetylase components (7). The human class I deacetylase
complex has been well characterized. It contains HDAC1y
HDAC2, RbAp46y48 (which may be involved in histone recog-
nition), SIN3 (which interacts with proteins such as Mad that
recruit the deacetylase complex to DNA), and proteins of
unknown function such as SAP30 and SAP18 (1). Most of these
proteins are conserved between yeast and humans (1). Interest-
ingly, SIN3 is not essential for HDAC1 deacetylase activity in
vitro but is essential in vivo (8, 9), presumably due to its role in
targeting RPD3 to promoters (1, 10, 11).
Class II deacetylases are similar to yeast HDA1, a putative
catalytic subunit, and include mammalian HDAC4, HDAC5,
and HDAC6. However, little is known about the protein com-
plexes that include these deacetylases (4). Yeast HDA1 was first
identified as a component of the HDA complex, referred to here
as the HDA1 complex (12). When the HDA1 complex was
purified to near homogeneity it was found to contain at least four
peptides: p75yHDA1, p73yHDA2, p72yHDA2, and p71y
HDA3. p73 and p72 are thought to represent posttranslationally
modified variants of HDA2 because their sequences were found
to be identical for each peptide analyzed (12). Because HDA1
and HDA3 were shown to coimmunoprecipitate and disruption
of HDA3 caused the loss of deacetylase activity from the
chromatographic profile HDA3 is required for HDA1 activity in
vitro. Recently, we reported the role of HDA1 in TUP1 repres-
sion (13). TUP1 is a repressor in yeast that affects pathways
involved in mating, DNA repair, oxygen and glucose utilization,
and osmotic stress (14–17). We have shown that TUP1 represses
gene activity in vivo in part through its utilization of HDA1 to
deacetylate histones H3 and H2B. This deacetylation occurs at
a localized region containing the TATA element adjacent to the
TUP1 recruitment site at ENA1 and STE6 (13).
In this work we have identified the encoded sequences of
HDA2 and HDA3 and have shown that HDA2 coimmunopre-
cipitates with HDA1 and HDA3. We also have used immuno-
precipitation, genetic disruptions, and direct binding glutathione
S-transferase (GST)-fusion experiments to determine the order
in which HDA1, HDA2, and HDA3 are associated with each
other within the deacetylase complex. Finally, we asked whether
HDA2 and HDA3 are required for the activity of the HDA1
deacetylase both in vitro and in vivo. The results of these
biochemical and genetic experiments are presented.
Materials and Methods
Yeast Strains. Please refer to the strain list in Table 1. The
hda1::TRP1 mutant allele was generated by transforming
pWJ118 (13) digested with SpeI into YDS2. The hda2::TRP1
mutant allele was generated by digesting pWJ202.1 with SpeIy
SacI to transform YDS2, resulting in WJY103. The hda3::TRP1
mutant allele was generated through digestion of pWJ302 with
SacIyKpnI to transform YDS2, resulting in WJY104. The
hda2::KAN, hda3::TRP1 double mutant strain WJY105 was
obtained by transforming SpeI-digested pWJ204.1 into WJY104.
To generate the HDA1::MYC::URA3 mutant allele, the plasmid
pHDA1–4 was digested with PflmI, and then transformed into
yeast strains YDS2, WJY103, WJY104, and WJY105, yielding
the WJY200, WJY203, WJY204, and WJY205 strains, respec-
tively. The HDA2::MYC::URA3 and the HDA3::MYC::URA3
mutant alleles were generated similarly, with pHDA2–4(HindIII
digested) and pHDA3–4(BglII digested). The integration or
deletion of these genes was confirmed by PCR.
Plasmid Construction. pWJ202.1 was made through the replace-
ment of the AseI fragment (encoding HDA2 amino acid residues
122–478) of plasmid pSKH2 with the 1.2-kb TRP1 gene, whereas
the plasmid pSKH2 was made by inserting the 2.5-kb SpeIyNheI
PCR fragment containing HDA2 gene and flanking sequence
into pBluescript KS(1) (Stratagene). pWJ204.1 was made
through the replacement of the AseI fragment of pSKH2 with
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2.5-kb KanMX4 gene pFA6a-KanMX4 (18). pWJ302 was con-
structed by replacing the EcoRVyHindIII fragment (encoding
HDA3 amino acid residues 54–607) of the plasmid pWJ301 with
the TRP1 gene. pWJ301 was constructed by inserting the 3.5-kb
EcoRIySacI PCR fragment containing the HDA3 gene sequence
into pBluescript KS(1). pHDA1–4 was made by inserting the
MYC-18 gene (SpeI fragment) (19) in-frame before the TAA of
HDA1 coding sequence in plasmid pHDA1–3. The SpeI site in
pHDA1–3 before the TAA of the HDA1 gene was made through
mutagenesis in plasmid pHDA1–2. pHDA1–2 was constructed
by subcloning the HDA1 gene (SacIyXhoI fragment containing
HDA1 C-terminal coding sequence and 39 sequence) into pBlue-
script KS(1). pHDA2–4 and pHDA3–4 were constructed in the
same way as pHDA1–4. pWJ153 was constructed by inserting the
PCR fragment of HDA1 coding sequence into the BamHIySalI
site pGEX-4T-1 to express GST-HDA1. The primers used were:
59-GACGGATCCATGGATTCTGTAATGGT-39 and 59-
AGCGTCGACTCATTCTTCATCACTCC-39. pWJ155 was
constructed by inserting the PCR fragment of the HDA3 coding
sequence into the BamHIySalI site pGEX-4T-1 to express
GST-HDA3. The primers used were: 59-GACGGATCCATG-
GATTTACTACGCAT-39 and 59-AGCGTCGACTTATA-
CATTTCCTGGTTT-39. pGST-HDA2(164–254) used for rais-
ing a-HDA2 antibody was constructed as follows. The HDA2
sequence was generated by PCR using the following oligonucle-
tides: 59- CGTGGATCCAGAACCAAGAGACTTTCCGG-39
and 59-GATGAATTCCAGCCAATAGGTATTGATCGTG-
39, and the PCR product was digested with BamHI and EcoRI
and ligated into the pGEX-2T (Amersham Pharmacia).
Protein Binding Assays. GST and GST fusion proteins were
expressed and purified in E. coli BL21(DE3) according to the
procedures provided by the manufacturer (Amersham Pharma-
cia). HDA1, HDA2, and HDA3 were translated in vitro with
plasmids pWJ402, pWJ403, pWJ406 (13), and the TNT in vitro
translation system, according to the procedures provided by the
manufacturer (Promega). Protein binding assays were per-
formed according to ref. 20. One hundred percent of the eluate
and 10% of the input materials were resolved by SDSyPAGE and
visualized by fluorography.
Immunoprecipitation and Histone Deacetylase Activity Assay. The
rabbit a-HDA2 antibody was generated against a GST-fusion
protein between amino acid residues 164–254 of the HDA2
protein by using standard procedures. Immunoprecipitation was
performed according to ref. 21. The a-HDA1 (12) antibody
(1:1,000) or a-myc antibody (1:20) coupled to Sepharose 4B-
beads (Babco, Richmond, CA) were added to the whole-cell
lysates for immunoprecipitation. The dilutions of antibodies for
Western blots were: a-HDA1, 1:3,000; a-HDA2, 1:1,000;
a-HDA3, 1:3,000; and a-myc, 1:1,000. Deacetylase activities
were assayed with half of the immunoprecipitated pellet. The
assay was carried out by using 3H-labeled HeLa histones as in
ref. 12.
Molecular Weight Determinations. Calculations to determine mo-
lecular weights were determined as in ref. 22. M 5 6 phNasy(1 2
vbarr) with M 5 molecular weight of the complex; p 5 3.142; h 5
the viscosity of the medium (0.01009 3 1028 gycm 3 sec); N 5
Avogadro’s number (6.02 3 1023); a 5 Stokes radius (60.3 3 1028
cm); s 5 the sedimentation coefficient (9.7 S); vbar 5 partial
specific volume (0.722); and r 5 the density of a 12.5% (average)
sucrose solution (1.047 gyml).
Chromatin Immunoprecipitation (Chr-IP) and PCR Analysis. Yeast
strains were grown to OD600 of 1.0 in yeast extractypeptoney
dextrose, and Chr-IPs were performed with the addition of 5 ml
antibody specific for each acetyl-lysine to 50 ml whole-cell extract
from 8 3 107 cells according to ref. 9. Antibodies to specific histone
acetylation sites are as described (13). PCR was performed with
1y100 of the immunoprecipitated DNA that was used as template.
32P-a-dATP was added to the PCR (1 mCiy12.5 ml) for quantitation
by PhosphorImager and IMAGEQUANT software (Molecular
Dynamics,). The TEL band was used as a loading control as
described (9). The primer pairs used to amplify the ENA1, DAL80,
and TEL promoter were as described (13). The primer pairs used
to amplify GAL10 were: 59-GGCGGCTTCTAATCCGTACT-
TCAA-39 and 59-ACCAATGTATCCAGCACCACCTGT-39. The
primer pairs used to amplify the HO gene were: 59-CATG-
ATGAAGCGTTCTAAACGCAC-39 and 59-TAGCCGTGACG-
TTTGCGATGTCTT-39.
Comparison of HDA2 and HDA3 Protein Similarity. The similarity
between HDA2 and HDA3 was determined by using the BLAST
program of the Saccharomyces Genome Database. The align-
ment between HDA2 and HDA3 was generated by using the
Smith–Waterman algorithm in the Saccharomyces Genome
Database.
Results and Discussion
Identification of HDA2 and HDA3. It was previously shown that
proteins with apparent relative molecular masses 75, 73, 72, and
Table 1. Yeast strains used in this study
Strain Relevant genotype Source
YDS21U MAT a, ade2-1, can1-100, his3-D200, leu2-3,112, trp1, URA3<TelVR Ref. 5
WJY127 Same as YDS21U except for hda1<TRP1 Ref. 13
WJY128 Same as YDS21U except for hda2<TRP1 This study
WJY129 Same as YDS21U except for hda3<TRP1 This study
YDS2 MAT a, ade2-1, can1-100, his3-D200, leu2-3,112, trp1, ura3-52 Ref. 5
WJY110 Same as YDS2 except for hda1<TRP1 This study
WJY103 Same as YDS2 except for hda2<TRP1 This study
WJY104 Same as YDS2 except for hda3<TRP1 This study
WJY105 Same as YDS2 except for hda2<TRP1, hda3<KAN This study
WJY200 Same as YDS2 except for HDA1<MYC18<URA3 This study
WJY201 Same as YDS2 except for HDA2<MYC18<URA3 This study
WJY202 Same as YDS2 except for HDA3<MYC18<URA3 This study
WJY203 Same as WJY103 except for HDA1<MYC18<URA3 This study
WJY204 Same as WJY104 except for HDA1<MYC18<URA3 This study
WJY205 Same as WJY105 except for HDA1<MYC18<URA3 This study
WJY211 Same as WJY201 except for hda1<TRP1 This study
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71 kDa copurify with histone deacetylase activity in the HDA
deacetylase complex (12). p75 was identified as HDA1, and four
other proteins (RPD3, HOS1, HOS2, and HOS3) were shown to
be highly homologous to HDA1 (5). p73 and p72 were designated
as HDA2 and p71 as HDA3. Peptide sequence analysis of HDA2
and HDA3 and their comparison to the yeast database identifies
HDA2 (GenBank accession no. U28374) as encoding 674 aa (77
kDa) and HDA3 (GenBank accession no. U25842) as encoding
655 aa (75.4 kDa). For reference, HDA1 encodes 706 aa (80
kDa). The alignment of HDA2 and HDA3 proteins shows ’21%
identity and 48.6% similarity over a region of 668 aa. HDA2 and
HDA3 contain four homologous domains (Fig. 1). Domain IV
of HDA2 (residues 449–630) and HDA3 (residues 475–650)
shows features of coiled-coil structure (Fig. 1). Neither of these
proteins have obvious homology with histone deacetylases or
with other proteins in either prokaryotic or eukaryotic data-
bases, and they appear to be novel proteins. Therefore, although
the coiled-coil sequence homology suggests that HDA2 and
HDA3 participate in protein–protein interactions in the deacety-
lase complex, they are not likely to be catalytic subunits.
HDA2 Coimmunoprecipitates with HDA1 and HDA3. HDA2 and
HDA3 cochromatograph with HDA1 (12). HDA1 and HDA3
also coimmunoprecipitate, indicating that these two proteins are
in the same macromolecular complex (12). To determine
whether HDA2 is a component of the deacetylase complex,
HDA2 and HDA3 genes were fused to 18 copies of the sequence
coding for the myc epitope at the 39 end of their coding regions.
Then they were integrated into the natural loci to replace the
HDA2 and HDA3 genes, resulting in strains WJY201 and
WJY202, respectively. Whole-cell extracts were prepared from
the wild-type (WT) YDS2 cells (which lack myc-tagged protein),
WJY201 and WJY202. a-HDA1 antibody and a-myc antibody
then were used to immunoprecipitate HDA1, HDA2-myc, and
HDA3-myc proteins from these extracts. The immunoprecipi-
tated materials were subjected to SDSyPAGE and Western
blotting in which a-HDA1, a-HDA2, and a-HDA3 antibodies
were used to detect the presence of HDA1, HDA2-myc, and
HDA3-myc proteins (Fig. 2A). We found that in strain YDS2
a-HDA1 antibody immunoprecipitates HDA1 (Fig. 2 A, lane 1),
HDA2 (Fig. 2 A, lane 4), and HDA3 (Fig. 2 A, lane 7). Using
WJY201, the HDA2-myc containing strain, we found that a-myc
antibody immunoprecipitates HDA2-myc (Fig. 2 A, lane 5),
HDA1 (Fig. 2 A, lane 2), and HDA3 (Fig. 2 A, lane 8). Finally,
in WJY202 the HDA3-myc containing strain, we found that
a-myc antibody immunoprecipitates HDA3-myc (Fig. 2 A, lane
9), HDA1 (Fig. 2 A, lane 3), and HDA2 (Fig. 2 A, lane 6). To rule
out the possibility of nonspecific interactions between a-myc
antibody and untagged proteins of the HDA1 complex, a-myc
antibody was incubated with the cell lysate from YDS2 (which
lacks myc-tagged protein). The precipitate was probed sepa-
rately with a-HDA1, a-HDA2, and a-HDA3 antibody (Fig. 2B).
It is evident that the a-myc antibody did not pull down either
untagged HDA1 (Fig. 2B, lane 2), HDA2 (Fig. 2B, lane 4), or
HDA3 (Fig. 2B, lane 6). Also, to guard against nonspecific
interactions between a-HDA1 antibody and HDA2 or HDA3,
immunoprecipitates from the hda1D strain (WJY110) were
probed with a-HDA2 and HDA3 antibodies (Fig. 2C). a-HDA1
antibody does not immunoprecipitate either HDA2 (Fig. 2C,
lane 4) or HDA3 (Fig. 2C, lane 6) from the hda1D mutant strain.
Therefore, we conclude that HDA1, HDA2, and HDA3 are
subunits of the same macromolecular complex.
HDA1 Coimmunoprecipitates with HDA2-HDA3 Subcomplex. To de-
termine the interactions that occur in vivo between HDA1,
HDA2, and HDA3 we examined the coimmunoprecipitation of
each of these components in genetic backgrounds lacking indi-
vidual HDA genes. Whole-cell extracts were prepared from WT
(YDS2), hda2D (WJY103), and hda3D (WJY104) cells. a-HDA1
antibody was used to immunoprecipitate the HDA1 complex
from these extracts, which subsequently were probed in Western
blots with a-HDA3 and a-HDA2 antibodies. First, we asked
whether interaction between HDA1 and HDA3 depends on
HDA2. When HDA2 was deleted, a-HDA1 antibody immuno-
precipitated only ’4% of HDA3 (Fig. 2D, lane 2) as compared
with the level seen in the WT strain containing HDA2 (Fig. 2D,
lane 1) and determined by densitometry. This is in part due to
the instability of HDA3 in the hda2D mutant strain (data not
shown). Therefore, HDA2 influences but is not essential for the
interaction between HDA1 and HDA3. Second, we asked
whether HDA3 mediates an interaction between HDA1 and
HDA2. We found in hda3D cells that no HDA2 can be detected
in the precipitates pulled down by a-HDA1 (Fig. 2D, lane 6). As
a control, we have shown that the amount of HDA2 is not
affected by the deletion of HDA3 (data not shown). These data
indicate that HDA3 is essential for the HDA1-HDA2 interac-
tion. Finally, to determine whether HDA1 is required for
interaction between HDA2 and HDA3, extracts were prepared
from WT (WJY201) and hda1D (WJY211) cells and a-myc
antibody was used to pull down HDA2-myc. The presence of
HDA3 was detected with a-HDA3 antibody. We found that
a-myc immunoprecipitates HDA3 as well in the hda1D strain as
in the HDA1 WT strain (Fig. 2D, lanes 7 and 8). Therefore the
association of HDA2 with HDA3 is independent of HDA1.
These data argue that HDA1 interacts with a subcomplex
containing HDA2-HDA3 largely through HDA3.
HDA1-HDA1 Coimmunoprecipitate. It has been shown that a mam-
malian histone deacetylase complex contains HDAC1 and
HDAC2, arguing for the presence of two similar, but noniden-
tical, RPD3-like catalytic subunits in the same complex (1).
Moreover, it was shown that HOS3 has intrinsic catalytic activity
as a homodimer when expressed in E. coli or yeast (7). To test
whether HDA1 interacts as a homodimer in the HDA1 complex,
two differently tagged HDA1 proteins were expressed simulta-
neously. One is tagged at its C terminus with myc18; the other
at its N terminus with GAL4-AD (GAD). The plasmid express-
ing GAD-HDA1 was transformed into cells (WJY200) contain-
ing the HDA1-MYC18 gene integrated at the natural HDA1
locus. We then asked whether immunoprecipitated HDA1-myc
also pulls down GAD-HDA1. Using a-myc and a-GAD anti-
bodies to detect the presence of these proteins in Western blots
we found (Fig. 2E) that a-myc antibody immunoprecipitates
HDA1-myc and GAD-HDA1 (Fig. 2E, lanes 1 and 5). There-
fore, HDA1-HDA1 interact directly or indirectly in the same
macromolecular complex.
To determine whether HDA2 or HDA3 mediate HDA1-
HDA1 interactions we examined the coimmunoprecipitation of
HDA1-myc18 and GAD-HDA1 in hda2D (WJY203), hda3D
(WJY204), and hda2Dhda3D (WJY205) mutant strains. As is
Fig. 1. HDA2 and HDA3 have sequence similarity in four domains including
one with potential coiled coil structure. Domain I: HDA2 (residues 12–33),
HDA3 (residues 31–52), identity 31%, similarity 52%; domain II: HDA2 (resi-
dues 84–177), HDA3 (residues 84–169), identity 36%, similarity 54%; domain
III: HDA2 (residues 238–299), HDA3 (residues 180–246), identity 25%, similar-
ity 46%; domain IV: HDA2 (residues 449–630), HDA3 (residues 475–650),
identity 23%, similarity 47%.
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shown in Fig. 2E lanes 2–4 and 6–8, the deletion of HDA2 and
HDA3 does not abolish the interaction between HDA1-myc and
GAD-HDA1. The tagging of different HDA1 molecules with
GAD and myc 18 in the same strain does not interfere with
interactions among HDA1, HDA2 and HDA3 in the WT
(WJY200) strain (data not shown). We also examined whether
there were interactions between HDA2 and HDA2 or between
HDA3 and HDA3 using the same approach and found no such
self-interactions (data not shown). We conclude that HDA1-
HDA1 interacts in a manner that is independent of HDA2 and
HDA3.
Direct Interactions Between HDA1-HDA1, HDA2-HDA3, and HDA1-
HDA3. To determine the direct protein–protein interactions
between HDA1, HDA2, and HDA3, GST-HDA1 and GST-
HDA3 were purified from E. coli, and 35S-labeled HDA1,
HDA2, and HDA3 were synthesized by using an in vitro trans-
lation system as described in Materials and Methods. First, we
asked whether there is a direct interaction between HDA1 and
HDA1 and between HDA1 and HDA3. It was found that
GST-HDA1 can pull down both HDA1 and HDA3 labeled with
35S (Fig. 3, lanes 3 and 9) whereas the GST protein alone cannot
do so (Fig. 3, lanes 2 and 8). Compared with input (Fig. 3, lanes
1 and 7), ’10% of total HDA1 and HDA3 bound to the
GST-HDA1 protein. In contrast, less than 1% 35S-labeled HDA2
binds to GST-HDA1 (Fig. 3, lanes 4 and 6). Next, we tested the
interaction between HDA2 and HDA3 by incubating 35S-labeled
HDA2 with GST-HDA3. It was found that GST-HDA3 precip-
itates ’60% of 35S-labeled HDA2, whereas GST alone cannot
retain HDA2 (Fig. 3, lanes 10 and 12). These direct binding
experiments demonstrate that HDA1 interacts directly with
HDA1 and HDA3. They also indicate that HDA2 interacts most
strongly with HDA3. The weakest interaction observed is be-
tween HDA1 and HDA2. These data support those of the
coimunoprecipitation experiments and argue that an HDA1-
HDA1 subcomplex interacts directly with an HDA2-HDA3
subcomplex, and that this interaction occurs most strongly
through HDA3.
By following HDA activity enzymatically as described (12)
with known protein standards and probing fractions by Western
blot we estimate from sucrose density gradient centrifugation an
S value of 9.7 S for the HDA1 complex (data not shown). Using
Superdex 200 chromatography the Stokes radius of the HDA1
complex was estimated to be 60.3 3 1028 cm (data not shown).
These values allow a calculation of the molecular mass of the
HDA1 complex at 299.2 kDa as described (Materials and Meth-
ods). The encoded molecular masses of HDA1, HDA2, and
Fig. 2. The interactions among the subunits of the HDA complex HDA1,
HDA2, and HDA3. (A) The HDA complex coimmunoprecipitates with any single
subunit of the complex. In lanes 1, 4, and 7, the whole-cell extracts were
prepared from YDS2 (containing the WT HDA1 gene). In lanes 2, 5, and 8,
strain WJY201 (containing HDA2::MYC gene) was used. In lanes 3, 6, and 9,
strain WJY202 (containing HDA3::MYC gene) was used. The antibodies used
for immunoprecipitation are shown. Blots were probed with a-HDA1 (lanes
1–3), a-HDA2 (lanes 4–6), and a-HDA3 (lanes 7–9). (B) The a-myc antibody does
not recognize HDA1, HDA2, or HDA3 lacking a myc tag. In lanes 1, 3, and 5,
strain WJY200 (HDA1::myc) was used. In lanes 2, 4, and 6, YDS2 (containing WT
HDA1, HDA2, and HDA3 with no myc tag) was used. Blots were probed with
a-HDA1 (lanes 1 and 2), a-HDA2 (lanes 3 and 4), and a-HDA3 (lanes 5 and 6).
(C) The a-HDA1 antibody does not recognize HDA2 or HDA3. In lanes 1, 3, and
5, strain YDS2 was used. In lanes 2, 4, and 6, the hda1D strain WJY110 was used.
Blots were probed with a-HDA1 (lanes 1 and 2), a-HDA2 (lanes 3 and 4), and
a-HDA3 (lanes 5 and 6). (D) The interaction between HDA2 and HDA3 is
independent of HDA1. In lanes 1–6, strains YDS2 (WT, lanes 1 and 4), WJY103
(hda2D, lanes 2 and 5) and WJY104 (hda3D, lanes 3 and 6) were used. In lanes
7 and 8, the strains WJY201 (WT, lane 7) and WJY211 (hda1D, lane 8) were
used, where the natural HDA2 gene has been replaced by HDA2::MYC. The
resulting blots were probed with a-HDA3 (lanes 1–3, 7, and 8) and a-HDA2
(lanes 4–6). (E) HDA1-HDA1 interact. HDA1 was tagged with myc18 in WT
(WJY200), hda2D (WJY203), hda3D (WJY204), and hda2Dhda3D (WJY205).
The plasmid expressing GAL4AD-HDA1 (pWJ104) was transformed into these
strains. a-Myc antibody was used to pull down HDA1-myc from cell extracts of
these strains, and a-myc antibody (lanes 1–4) and a-GAL4 AD antibody (lanes
5–8) were used to detect the presence of HDA1-myc and GAL4-AD-HDA1. IP,
immunoprecipitation.
Fig. 3. Direct interactions between HDA1, HDA2, and HDA3. 35S-
Methionine-labeled HDA1, HDA2, and HDA3 were incubated with GST (lanes
2, 5, and 8) or GST-HDA1 (lanes 3, 6, and 9) and immobilized on glutathione-
Sepharose beads. 35S-Methionine-labeled HDA2 was incubated with GST (lane
11) and GST-HDA3 (lane 12). The interactions were analyzed according to
Materials and Methods.
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HDA3 are 80, 77, and 75.4 kDa, respectively. Therefore we
estimate the expected molecular mass of a tetrameric complex
containing two molecules of HDA1 to be 312.5 kDa. Because
this size correlates well with the molecular mass determined
above and we do not find other proteins in the HDA1 complex
(12), it is suggested that the HDA1 complex contains a protein
tetramer. Interestingly, HOS3 assembles to form a homodimer
in yeast and E. coli and it is as a homodimer that it has intrinsic
activity (7). Also, HDAC1 and HDAC2 deacetylases have been
found in the same HDAC complex in mammalian cells (1). Thus
all deacetylase complexes characterized to date, including
HDA1, contain at least two putative catalytic deacetylase mol-
ecules. Because each nucleosome octamer contains two mole-
cules of each of the four core histone proteins the dimeric HDA1
catalytic component may be required for the deacetylation of
both molecules.
HDA2 Is Important for the in Vitro Activity of the HDA1 Complex. To
determine the extent to which HDA2 and HDA3 influence
activity of the HDA1 deacetylase, a-HDA1 antibody was used to
immunoprecipitate histone deacetylase activity from whole-cell
extracts of WT (YDS2), hda1D (WJY110), hda2D (WJY103),
hda3D (WJY104), and hda2Dhda3D (WJY105) mutant cells.
Deacetylase activity was assayed as described (12) using 3H-
labeled HeLa core histones as substrate. As shown in Fig. 4A, the
deacetylase activity of the WT extract is decreased to back-
ground levels when HDA1 is deleted (hda1D). hda2D, hda3D, and
hda2Dhda3D all cause a similar decrease in deacetylase activity.
Moreover, the amounts of HDA1 immunoprecipitated from
each of the above strains (except for the hda1D strain) are similar
as determined by Western blotting (Fig. 4B). Therefore, both
HDA2 and HDA3 are required for HDA1 activity in vitro.
HDA1, HDA2, and HDA3 Are Required for H3yH2B-Specific Deacetyla-
tion of the ENA1 Promoter in Vivo. We next asked whether HDA2
and HDA3 are required for the in vivo deacetylation of chro-
matin. Chr-IP with antibodies directed against individual sites of
acetylation in histones has been used to determine the role of
HDA1 in deacetylating histones at TUP1-regulated genes such
as ENA1. These experiments demonstrate that HDA1 is re-
quired specifically for deacetylation of all H3 and H2B sites of
acetylation examined but not H4 or H2A sites (13). Therefore,
we wanted to determine whether HDA2 and HDA3 are required
for similar deacetylation in vivo. Using Chr-IP we examined the
acetylation levels of all four core histones at the ENA1 promoter
in WT (YDS21U), hda1D (WJY127), hda2D (WJY128), or
Fig. 4. HDA2 and HDA3 are required for the in vitro deacetylase activity of
the HDA1 complex. a-HDA1 antibody was used to immunoprecipitate histone
deacetylase activity from whole-cell extracts. Yeast strains YDS2 (WT), WJY110
(hda1D), WJY103 (hda2D), WJY104 (hda3D), and WJY105(hda2Dhda3D) were
used. Half of each precipitate was used to assay the enzymatic activity (A) and
half to determine the amount of the HDA1 protein by Western blot (B).
Fig. 5. HDA2 and HDA3 are required for deacetylation of histones H3 and H2B by HDA1 at the ENA1 promoter. Chr-IP demonstrating the effects of hda1D,
hda2D, and hda3D on the acetylation of (A) H4 sites K5, K8, K12, and K16; (B) H3 sites K9, K14, K18, K23, and K27; and (C) H2A site K7 and H2B sites K11 and
K16 at the ENA1, GAL10, and HO promoters. Amplification of a 138-bp fragment 0.5 kb from the telomere (Tel) of chromosome VI-R was used as reference to
ensure equal loading of samples. Yeast strains used for Chr-IP are WT (YDS2), hda1D (WJY127), hda2D, (WJY128), and hda3D (WJY129). HO was found to be
relatively unaffected by HDA1 disruption and was used as a negative control. (D) Quantification of increases in H3 and H2B acetylation in hda1D, hda2D, and
hda3D cells relative to WT cells. 32P-a-dATP was added to the PCR mixture, and the PhosphorImager was used to quantitate the intensity of ENA1 PCR bands in
the hda1D, hda2D, and hda3D mutants relative to WT after normalizing to the Tel bands.
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hda3D (WJY129) strains as described (13). PCR amplification
was performed on the promoters of the ENA1, GAL10, and HO
genes as well as a subtelomeric region TEL, 500 bp from the end
of chromosome VI-R. TEL is used as a loading control because
its acetylation state is not affected by HDA1 mutation (9).
GAL10 is weakly regulated by TUP1, whereas HO is not. It was
found at ENA1 that H3 sites (K9, K14, K18, K23, and K27) and
H2B sites (K11 and K16) are hyperacetylated in a similar manner
by hda1D, hda2D, or hda3D as compared with the WT control
(Fig. 5 B and C; quantitated in Fig. 5D). H4 sites (K5, K8, K12,
K16) and H2A site (K7) were relatively unaffected by any of
these deletions (Fig. 5 A and C). GAL10 is affected more weakly
but in a similar manner by hda1D, hda2D, or hda3D, and HO is
apparently unaffected by these deletions (Fig. 5 B and C;
quantitations not shown). These data demonstrate that HDA2
and HDA3 are required for the deacetylation of ENA1 (and
GAL10) by HDA1.
HDA1, HDA2, and HDA3 Disruptions All Increase Expression of ENA1.
Because it has been shown that HDA1 represses the transcrip-
tion of ENA1 (13), we wanted to determine the effects of the
disruption of HDA2 and HDA3 genes on ENA1 promoter
activity. The ENA1-lacZ gene in which the ENA1 promoter was
fused to the LacZ reporter gene (23) was integrated into the
URA3 locus of WT (YDS2), hda1D (WJY110), hda2D
(WJY103), and hda3D (WJY104) yeast. Transcription from the
ENA1 promoter was determined by b-galactosidase activity. Fig.
6 shows that the disruptions of HDA1, HDA2, or HDA3 all cause
approximate 2-fold increase in ENA1-lacZ transcription. We
conclude that HDA2 and HDA3 are repressors of ENA1 in a
manner similar to that of HDA1. Moreover, it has been shown
that HDA1 disruption increases silencing (telomere position
effect, TPE) of URA3 integrated at 2.1 kb from the telomere (5).
We find that HDA1, HDA2, and HDA3 disruptions all increase
TPE to a similar extent (5.3- to 5.8-fold) (data not shown).
Therefore, we conclude that interaction between the HDA1-
HDA1 homodimer with the HDA2-HDA3 heterodimer is es-
sential for the catalytic activity of the HDA1 complex in vitro and
for all known functions in vivo. Because HDA1 is likely to be the
catalytic subunit and interacts directly with the repression do-
main of TUP1 in vitro (13), it is interesting to speculate on the
functions of the other two components. HDA3 also may be
involved in TUP1 binding (13); however, these interactions
cannot be necessary for the activity of the catalytic subunit in
vitro because TUP1 is absent from these reactions. Conse-
quently, it is possible that HDA2 and HDA3 are involved in
histone recognition or in altering the structure of the HDA1
dimer in a manner that allows its activity. HDA2 also contains
the consensus attachment site at residues 570–585 for phospho-
pantetheine, the prosthetic group of acyl carrier proteins (doc-
umented by Saccharomyces Genome DatabaseyMunich Infor-
mation Center for Protein Sequences). This raises the intriguing
possibility that a noncatalytic component of a deacetylase com-
plex may be required for the capture or transfer of acetyl groups
released during histone deacetylation.
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Fig. 6. HDA2 and HDA3 are essential for repression by HDA1. Expression of
ENA1-LacZ was derepressed in hda1D, hda2D, and hda3D mutants. Plasmid
pFR70i harboring ENA-LacZ was integrated into the URA3 loci of the chromo-
somes of WT (YDS2), hda1D (WJY110), hda2D (WJY103), and hda3D (WJY104).
b-Galactosidase activity is shown in Miller units. Values represent averages for
4–6 transformants. Standard errors were ,5%.
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